Related Experiment Video
Updated: Jul 19, 2026
05:30
Cercarial Transformation and in vitro Cultivation of Schistosoma mansoni Schistosomules
Published on: August 16, 2011
A Vaccine for Schistosomiasis: alternative approaches
Parasitology Today (Personal Ed.)
|October 17, 2006
Summary
A recent Schistosoma mansoni vaccine trial failed. Future research should explore alternative antigens, like schistosome larval protease and egg/worm antigens, which show promise despite unusual immunological properties.
Area of Science:
- Parasitology
- Immunology
- Vaccine Development
Background:
- Schistosomiasis remains a significant global health concern.
- A recent Schistosoma mansoni vaccine trial, supported by the World Health Organization TDR programme, did not meet expectations.
- Evaluating alternative vaccine candidates is crucial for advancing schistosomiasis control.
Purpose of the Study:
- To discuss potential alternative antigens for a Schistosoma mansoni vaccine.
- To highlight two specific S. mansoni molecules with potential protective immunity.
- To suggest future research directions for schistosomiasis vaccine development.
Main Methods:
- Review of findings from a completed independent trial of candidate Schistosoma mansoni vaccine antigens.
- Description of two S. mansoni molecules: a schistosome larval protease and a high molecular weight egg and worm antigen.
- Analysis of the immunological properties of these candidate antigens.
Main Results:
- The independent trial of candidate Schistosoma mansoni vaccine antigens did not meet expectations.
- Two S. mansoni molecules, a larval protease and a high molecular weight egg/worm antigen, are associated with protective immunity.
- These molecules possess unusual immunological properties distinct from previously tested antigens.
Conclusions:
- Alternative approaches to a Schistosoma mansoni vaccine are still warranted.
- Further investigation into schistosome larval protease and high molecular weight egg/worm antigens is suggested.
- Exploring novel antigens may overcome limitations of previous vaccine strategies.
Related Concept Videos
01:15Anthelminthic Agents
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
01:21Antiprotozoal Agents
Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...
01:30Leishmaniasis
Leishmaniasis is a protozoal disease caused by species of the genus Leishmania and transmitted through the bite of infected female sandflies. The parasite exists in two principal morphological forms during its life cycle. A sandfly acquires intracellular amastigotes from an infected reservoir host, such as a dog. Within the sandfly, these forms differentiate into motile, flagellated promastigotes. During a subsequent blood meal, promastigotes are injected into the human host, where they...
01:12Giardiasis
Giardiasis is a globally prevalent intestinal infection caused by the protozoan parasite Giardia duodenalis (also known as G. lamblia or G. intestinalis). This flagellated protozoan is the most frequently identified intestinal parasite in the United States and worldwide. Transmission primarily occurs via the fecal-oral route, with infection arising from ingestion of water or food contaminated with cysts. Individuals in low-resource settings, international travelers, outdoor enthusiasts, daycare...
01:28Toxoplasmosis
Toxoplasmosis, a zoonotic disease caused by the protozoan Toxoplasma gondii, poses significant public health challenges globally due to its high seroprevalence and varied clinical manifestations. As an obligate intracellular parasite, T. gondii can infect all warm-blooded vertebrates, but felids are its only definitive hosts, shedding unsporulated oocysts into the environment. Humans typically acquire the infection through ingestion of tissue cysts in undercooked meat or oocysts from...